Capital Markets Day

The sections below include presentations, webcasts and comprehensive educational information on all business activities of Merck KGaA, Darmstadt, Germany.

Capital Markets Day

At our Capital Markets Day 2023, the Executive Board will discuss the latest developments and future plans to continue our success story and journey of profitable growth.

Oct. 19, 2023

Capital Markets Day 2023


Agenda CMD Oct. 19, 2023	PDF
CMD Oct. 19, 2023 – live webcast 10 a.m. - 12:30 p.m. CEST
Group CEO & CFO Presentation
Sector afternoon sessions for on-site participants only

Comprehensive material from past events

Available information
- Agenda
- News Release
Presentations

Group CEO & CFO Presentation PDF
Group ESG Presentation PDF
Available information
- Agenda
- News Release
Presentations

Group CEO Presentation

Group CFO Presentation

Healthcare Presentation

Life Science Presentation

Electronics Presentation

PDF

PDF

PDF

PDF

PDF

Available information
- Agenda
- News Release
Presentations
- Supporting slides: PDF
Available information
- Agenda
- News Release
Presentations
- Supporting slides: PDF
Available information
- Agenda
- News Release
Presentations
- Supporting slides: PDF
Available information
- Agenda
- News Release
Presentations
- Stefan Oschmann: Focus on value creation
- Marcus Kuhnert: Proof of value creation
Available information
- Agenda
Presentations
- Karl-Ludwig Kley: The Journey of Merck KGaA, Darmstadt, Germany 2007 - 2015
- Stefan Oschmann: Deliver on Growth
- Marcus Kuhnert: Financial Perpectives
Available information
- Stefan Oschmann, CEO Pharma: Introduction
- Belen Garijo, President & CEO of EMD Serono: Introduction
- Marcus Kuhnert, CFO: Introduction
Presentations
- Karl-Ludwig Kley: Strategic perspective on Merck KGaA, Darmstadt, Germany
- Stefan Oschmann: Taking EMD Serono to the next level of value generation
- Belen Garijo: Roadmap to sustainable success
- Luciano Rossetti: A first take on R&D at EMD Serono
- Harsukh Parmar: Immunology - from symptom relief to disease modification
- Andrew Schiermeier/Andree Blaukat: Oncology - building on our established strengths
- Helen Sabzevari: ImmunoOncology - cancer therapy powered by the immune system
- Simon Sturge: Biosimilars - a compelling fit for Merck KGaA, Darmstadt, Germany
- Marcus Kuhnert: Merck KGaA, Darmstadt, Germany - financial perspective on value creation
Presentations
- Dr. Bernd Reckmann, Member of the Executive Board: Leadership built on unique strengths
- Walter Galinat, President of Electronics: Characteristics of the liquid crystals market
- Michael Heckmeier, Senior Vice President LC: Shaping the future of liquid crystals
- Udo Heider, Vice President OLED: OLED and respective position of Merck KGaA, Darmstadt, Germany
- Thomas Kietzke, Director Strategy and Market Intelligence: LCDs – a high hurdle for new large display technologies
- Matthias Zachert, CFO: Liquid Crystals - sustained value contribution
Presentations
- Dr. Bernd Reckmann, Member of the Executive Board
- Robert Yates, Head of EMD Millipore
- Matthias Zachert, CFO
- Breakout Session: Process Solutions
- Breakout Session: Bioscience Solutions
- Breakout Session: Lab Solutions
Presentations